Literature DB >> 20712710

Establishment and characterization of the rhabdomyosarcoma cell line designated NUTOS derived from the human tongue sarcoma: Special reference to the susceptibility of anti-cancer drugs.

Minako Suzuki1, Noriko Tominaga, Yoshiaki Ide, Akihiro Ohyama, Taka Nakahara, Hiroshi Ishikawa, Akira Tanaka, Izumi Mataga.   

Abstract

Primary alveolar type of rhabdomyosarcoma (RMS) tumor tissue was collected from the tongue of a 17-year-old Japanese woman and used to successfully establish a rhabdomyosarcoma cell line, which has been designated NUTOS. The chromosomal distribution revealed that the NUTOS cell line was hyper-tetraploid with chromosomal translocation. The cells were grown in Dulbecco's modified eagle medium/F12 supplemented with 15% fetal bovine serum, 0.1% non-essential amino acids solution (NEAA), 50 microg of streptomycin, 50 U/mL of penicillin and 0.25 microg /mL of Fungizone. The NUTOS shapes included small spindles, large spindles and long, thick multinucleated cells. All three cell types were immunostained with anti-desmin antibody, which is a marker protein for middle sized myofilaments. Furthermore, immunocytochemical staining revealed that the cells were positively immunostained with anti-MyoD, myogenin, alpha-sarcomeric actin, myosin and troponin T. Mitotic figures were only observed in the small spindle cells. These cells were coadunated with each other at the lateral portion of the apex of the cells. Subsequently, these cells grew into large multinucleated cells. Autonomic contractions (approximately 20 times/min) were observed in both the large spindle cells and the large multinucleated cells. NUTOS cells incorporated serotonin from the serum in the growth medium. Histopathological observations of the NUTOS cell grafts in the subcutis of nude mice exhibited characteristics similar to those seen for the primary rhabdomyosarcoma of the tongue. Susceptibility tests for the anti-cancer drugs revealed that NUTOS cells were susceptive to cisplatin, paclitaxel, and docetaxel, but not to adriacin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712710     DOI: 10.1111/j.1749-0774.2010.00086.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  22 in total

Review 1.  Measuring respiration of cultured cell with oxygen electrode as a metabolic indicator for drug screening.

Authors:  Y Amano; C Okumura; M Yoshida; H Katayama; S Unten; J Arai; T Tagawa; S Hoshina; H Hashimoto; H Ishikawa
Journal:  Hum Cell       Date:  1999-03       Impact factor: 4.174

Review 2.  Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

Authors:  R B Raney; J R Anderson; F G Barr; S S Donaldson; A S Pappo; S J Qualman; E S Wiener; H M Maurer; W M Crist
Journal:  J Pediatr Hematol Oncol       Date:  2001-05       Impact factor: 1.289

3.  Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study.

Authors:  D M Hays; S S Donaldson; H Shimada; W M Crist; W A Newton; R J Andrassy; E Wiener; J Green; T Triche; H M Maurer
Journal:  Med Pediatr Oncol       Date:  1997-09

Review 4.  Clinical and pathologic features of primary gastric rhabdomyosarcoma.

Authors:  K R Fox; S M Moussa; R J Mitre; B L Zidar; J J Raves
Journal:  Cancer       Date:  1990-08-15       Impact factor: 6.860

5.  The Intergroup Rhabdomyosarcoma Study-II.

Authors:  H M Maurer; E A Gehan; M Beltangady; W Crist; P S Dickman; S S Donaldson; C Fryer; D Hammond; D M Hays; J Herrmann
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

6.  Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

Authors:  W A Newton; E A Gehan; B L Webber; H B Marsden; A J van Unnik; A B Hamoudi; M G Tsokos; H Shimada; D Harms; D Schmidt
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

7.  Rhabdomyosarcoma of the head and neck in children.

Authors:  J Hicks; C Flaitz
Journal:  Oral Oncol       Date:  2002-07       Impact factor: 5.337

8.  A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan.

Authors:  Hajime Hosoi; Satoshi Teramukai; Yoshifumi Matsumoto; Kunihiko Tsuchiya; Tomoko Iehara; Jun-ichi Hara; Tetsuo Mitsui; Michio Kaneko; Yoshiro Hatae; Yutaka Hayashi; Osamu Mabuchi; Naoto Adachi; Yasuhide Morikawa; Shin-ichiro Nishimura; Masaaki Kumagai; Hideo Takamatsu; Tadashi Sawada; Tohru Sugimoto
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

Review 9.  Biology and therapy of pediatric rhabdomyosarcoma.

Authors:  A S Pappo; D N Shapiro; W M Crist; H M Maurer
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

10.  Characterization, anticancer drug susceptibility and atRA-induced growth inhibition of a novel cell line (HUMEMS) established from pleural effusion of alveolar rhabdomyosarcoma of breast tissue.

Authors:  Satoshi Ohi
Journal:  Hum Cell       Date:  2007-05       Impact factor: 4.174

View more
  5 in total

1.  In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow.

Authors:  Yuichi Tamaki; Taka Nakahara; Hiroshi Ishikawa; Soh Sato
Journal:  Odontology       Date:  2012-07-07       Impact factor: 2.634

2.  Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line.

Authors:  Eiji Takaoka; Hiroshi Sonobe; Kunihiro Akimaru; Shuji Sakamoto; Taro Shuin; Masanori Daibata; Takahiro Taguchi; Akira Tominaga
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

3.  Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue.

Authors:  Minako Suzuki; Hiroshi Ishikawa; Akira Tanaka; Izumi Mataga
Journal:  Hum Cell       Date:  2010-12-29       Impact factor: 4.174

4.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

5.  Establishment and characterization of METON myoepithelioma cell line derived from human palatal myoepithelioma: apical reference to the diverse differentiation potential.

Authors:  Minako Suzuki; Hiroshi Ishikawa; Miyuki Kawakami; Taka Nakahara; Akira Tanaka; Izumi Mataga
Journal:  Hum Cell       Date:  2013-06-13       Impact factor: 4.174

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.